BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35701438)

  • 1. Publisher Correction: Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3
    Zhou Q; Lin W; Wang C; Sun F; Ju S; Chen Q; Wang Y; Chen Y; Li H; Wang L; Hu Z; Jin H; Wang X; Sun Y
    Nat Commun; 2022 Jun; 13(1):3424. PubMed ID: 35701438
    [No Abstract]   [Full Text] [Related]  

  • 2. Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3
    Zhou Q; Lin W; Wang C; Sun F; Ju S; Chen Q; Wang Y; Chen Y; Li H; Wang L; Hu Z; Jin H; Wang X; Sun Y
    Nat Commun; 2022 May; 13(1):3034. PubMed ID: 35641493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of Cullin 3 E3 ligases in tumorigenesis.
    Cheng J; Guo J; Wang Z; North BJ; Tao K; Dai X; Wei W
    Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):11-28. PubMed ID: 29128526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88/NF-κB signaling.
    Jin X; Shi Q; Li Q; Zhou L; Wang J; Jiang L; Zhao X; Feng K; Lin T; Lin Z; Zhuang H; Yang J; Hu C; Zhang L; Shen L; Lu Y; Zhu J; Wang H; Qi H; Meng X; Xi Y; Pan J; Fang S; Tian H; Zhou C; Zhang P; Gao K; Zhao SM; Li Y; Gong Z; Wang C
    Leukemia; 2020 May; 34(5):1305-1314. PubMed ID: 31776466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.
    Li XM; Wu HL; Xia QD; Zhou P; Wang SG; Yu X; Hu J
    Biomed Pharmacother; 2022 May; 149():112882. PubMed ID: 35364375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
    Zhou H; Lu J; Yang CY; Sun Y; Wang S
    Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
    Shi L; Yan Y; He Y; Yan B; Pan Y; Orme JJ; Zhang J; Xu W; Pang J; Huang H
    Cancer Res; 2021 Jul; 81(13):3593-3606. PubMed ID: 33762355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPOP Mutations or ERG Rearrangements Result in Enhanced Levels of ERG to Promote Cell Invasion in Prostate Cancer.
    Duan S; Pagano M
    Mol Cell; 2015 Sep; 59(6):883-4. PubMed ID: 26384661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
    Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
    Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer.
    Guo ZQ; Zheng T; Chen B; Luo C; Ouyang S; Gong S; Li J; Mao LL; Lian F; Yang Y; Huang Y; Li L; Lu J; Zhang B; Zhou L; Ding H; Gao Z; Zhou L; Li G; Zhou R; Chen K; Liu J; Wen Y; Gong L; Ke Y; Yang SD; Qiu XB; Zhang N; Ren J; Zhong D; Yang CG; Liu J; Jiang H
    Cancer Cell; 2016 Sep; 30(3):474-484. PubMed ID: 27622336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.
    Marzahn MR; Marada S; Lee J; Nourse A; Kenrick S; Zhao H; Ben-Nissan G; Kolaitis RM; Peters JL; Pounds S; Errington WJ; Privé GG; Taylor JP; Sharon M; Schuck P; Ogden SK; Mittag T
    EMBO J; 2016 Jun; 35(12):1254-75. PubMed ID: 27220849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase.
    Zhu H; Ren S; Bitler BG; Aird KM; Tu Z; Skordalakes E; Zhu Y; Yan J; Sun Y; Zhang R
    Cell Rep; 2015 Nov; 13(6):1183-1193. PubMed ID: 26527005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
    Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
    Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYB106 is a negative regulator and a substrate for CRL3
    Hong L; Niu F; Lin Y; Wang S; Chen L; Jiang L
    J Integr Plant Biol; 2021 Jun; 63(6):1104-1119. PubMed ID: 33470537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression.
    He W; Zhang J; Liu B; Liu X; Liu G; Xie L; He J; Wei M; Li K; Ma J; Dong R; Ma D; Dong K; Ye M
    Mol Ther Oncolytics; 2020 Dec; 19():149-162. PubMed ID: 33209975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
    Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
    Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells.
    Gao K; Jin X; Tang Y; Ma J; Peng J; Yu L; Zhang P; Wang C
    Am J Cancer Res; 2015; 5(10):3210-20. PubMed ID: 26693071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPOP and cancer: a systematic review.
    Clark A; Burleson M
    Am J Cancer Res; 2020; 10(3):704-726. PubMed ID: 32266086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear ubiquitin ligase adaptor SPOP is a conserved regulator of C9orf72 dipeptide toxicity.
    Snoznik C; Medvedeva V; Mojsilovic-Petrovic J; Rudich P; Oosten J; Kalb RG; Lamitina T
    Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34593637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.
    Ma J; Shi Q; Cui G; Sheng H; Botuyan MV; Zhou Y; Yan Y; He Y; Wang L; Wang Y; Mer G; Ye D; Wang C; Huang H
    Nat Commun; 2021 Oct; 12(1):5779. PubMed ID: 34599168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.